BATTISTUTTA, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 6.736
AS - Asia 1.821
EU - Europa 1.356
AF - Africa 374
SA - Sud America 354
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 19
Totale 10.700
Nazione #
US - Stati Uniti d'America 6.542
SG - Singapore 581
CN - Cina 467
DE - Germania 282
HK - Hong Kong 277
BR - Brasile 238
FI - Finlandia 203
IT - Italia 201
VN - Vietnam 112
SE - Svezia 67
GB - Regno Unito 66
UA - Ucraina 63
RU - Federazione Russa 57
FR - Francia 56
PL - Polonia 50
NL - Olanda 38
IN - India 32
IE - Irlanda 25
CI - Costa d'Avorio 20
MX - Messico 20
AR - Argentina 19
CA - Canada 19
KZ - Kazakistan 19
UZ - Uzbekistan 19
AT - Austria 18
JP - Giappone 16
TR - Turchia 16
AE - Emirati Arabi Uniti 15
BA - Bosnia-Erzegovina 15
GN - Guinea 15
MA - Marocco 15
DZ - Algeria 14
GA - Gabon 14
GF - Guiana Francese 14
KR - Corea 14
NE - Niger 14
NI - Nicaragua 14
SA - Arabia Saudita 14
TT - Trinidad e Tobago 14
AU - Australia 13
BD - Bangladesh 13
CV - Capo Verde 13
HN - Honduras 13
TH - Thailandia 13
ZA - Sudafrica 13
AD - Andorra 12
AZ - Azerbaigian 12
CL - Cile 12
ES - Italia 12
IL - Israele 12
KG - Kirghizistan 12
PE - Perù 12
AL - Albania 11
CH - Svizzera 11
GT - Guatemala 11
HT - Haiti 11
IQ - Iraq 11
LA - Repubblica Popolare Democratica del Laos 11
PY - Paraguay 11
RE - Reunion 11
RW - Ruanda 11
SI - Slovenia 11
TN - Tunisia 11
VE - Venezuela 11
AM - Armenia 10
BE - Belgio 10
BF - Burkina Faso 10
BO - Bolivia 10
CO - Colombia 10
EC - Ecuador 10
EG - Egitto 10
IR - Iran 10
JO - Giordania 10
LB - Libano 10
PR - Porto Rico 10
PT - Portogallo 10
RO - Romania 10
TL - Timor Orientale 10
BG - Bulgaria 9
BJ - Benin 9
BY - Bielorussia 9
DJ - Gibuti 9
DO - Repubblica Dominicana 9
ET - Etiopia 9
GE - Georgia 9
GH - Ghana 9
KE - Kenya 9
KH - Cambogia 9
LV - Lettonia 9
MU - Mauritius 9
MY - Malesia 9
SK - Slovacchia (Repubblica Slovacca) 9
SN - Senegal 9
TJ - Tagikistan 9
UG - Uganda 9
XK - ???statistics.table.value.countryCode.XK??? 9
ZW - Zimbabwe 9
CM - Camerun 8
CW - ???statistics.table.value.countryCode.CW??? 8
EE - Estonia 8
Totale 10.324
Città #
Fairfield 987
Woodbridge 688
Ann Arbor 551
Ashburn 547
Houston 503
Chandler 450
Singapore 374
Seattle 355
Wilmington 319
Cambridge 305
Jacksonville 297
Hong Kong 263
Munich 159
Santa Clara 141
Princeton 134
Beijing 125
Boardman 121
Helsinki 109
San Diego 93
Padova 90
Roxbury 70
Des Moines 57
Nanjing 52
Bytom 38
Medford 36
Los Angeles 33
Dong Ket 30
Chicago 24
Dublin 23
Ho Chi Minh City 23
Shenyang 23
Hefei 22
Nanchang 20
São Paulo 20
Abidjan 19
Tashkent 18
Buffalo 17
Hanoi 17
Guangzhou 16
Hebei 16
London 16
Falls Church 15
Conakry 14
Changsha 13
Managua 13
Niamey 13
Norwalk 13
Ogden 13
Andorra la Vella 12
Baku 12
Bishkek 12
Libreville 12
New York 12
Vienna 12
Cayenne 11
Jinan 11
Kigali 11
Washington 11
Amman 10
Brooklyn 10
Dili 10
Jiaxing 10
Turku 10
Dakar 9
Dushanbe 9
Harare 9
Praia 9
San Francisco 9
Stockholm 9
Tokyo 9
Vientiane 9
Yerevan 9
Accra 8
Antananarivo 8
Bamako 8
Bangkok 8
Boston 8
Lima 8
Nouakchott 8
Ouagadougou 8
Riga 8
Rome 8
Seoul 8
Warsaw 8
Willemstad 8
Belo Horizonte 7
Castries 7
Chennai 7
Chisinau 7
Dar es Salaam 7
Havana 7
Kampala 7
Lusaka 7
Minsk 7
Nairobi 7
Panama City 7
Phnom Penh 7
Port-au-Prince 7
Redondo Beach 7
Reykjavik 7
Totale 7.751
Nome #
ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update 239
Calmodulin binds to the STAS domain of SLC26A5 prestin with a calcium-dependent, one-lobe, binding mode 234
Structure of the Cytosolic Portion of the Motor Protein Prestin and Functional Role of the STAS Domain in SLC26/SulP Anion Transporters 221
Crystal Structure of Amine Oxidase from Bovine Serum 212
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight. 205
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 202
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA) 201
Axonal Odorant Receptors Mediate Axon Targeting 188
A structural insight into CK2 inhibition 180
Structure of the neutrophil activating protein from helicobacter pylori 172
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype 168
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2 158
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential 155
Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin 155
TAP score: torsion angle propensity normalization applied to local protein structure evaluation 154
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 152
Crystal structure of CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for a type IV secretion system 151
The Replacement of ATP by the Competitive Inhibitor Emodin Induces Conformational Modifications in the Catalytic Site of Protein Kinase CK2 151
Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole 149
IDENTIFICATION OF NEW SARS-COV-2 MAIN PROTEASE INHIBITORS BY AN INTEGRATED IN-SILICO AND IN-VITRO STRATEGY 148
Probing an Allosteric Pocket of CDK2 with Small Molecules 148
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 148
Crystallization and preliminary X-ray data of amine oxidase from bovine serum 147
Structure at 1.44 A resolution of a N-terminally truncated form of rat serum complement C3d,g fragment 146
A novel class of selective CK2 inhibitors targeting its open hinge conformation 146
Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain 143
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A 142
Crystal structure and refolding properties of the mutant F99S/M153T/V163A of the Green Fluorescent Protein 142
Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole 141
Conformation of Retro-bombolitin-i In Aqueous-solution Containing Surfactant Micelles 139
pH-Dependent Conformational Changes and Topology of Herpesvirus Translocating Peptide in a Membrane-Mimetic Enviroment. 131
Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2. 131
Structural Determinants of Protein Kinase CK2 Regulation by Autoinhibitory Polymerization 129
Structure and single crystal spectroscopy of Green Fluorescent Proteins 128
Crystal structure of alkyl hydroperoxide-reductase (AhpC) from Helicobacter pylori 127
Active Form of the Protein Kinase CK2 alpha(2)beta(2) holoenzyme Is a Strong Complex with Symmetric Architecture 126
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules 125
The crystal structure of CagS from the Helicobacter pylori pathogenicity island. 124
The STAS domain of mammalian SLC26A5 prestin harbours an anion-binding site 123
Structure of two iron-binding proteins from Bacillus anthracis 122
Crystal structure of the PsbQ protein of photosystem II from higher plants 121
Circular dichroism and 1H-NMR studies on bombolitin-related peptides in aqueous solution containing SDS-micelles 121
Expression, purification and characterisation of the C-terminal STAS domain of the SLC26 anion transporter prestin 120
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation 120
Toward the rational design of protein kinase casein kinase-2 inhibitors 119
Inhibitors of protein kinase CK2: structural aspects 118
Does CK2 start chromatin condensation in mitotic phase? 118
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility 117
A new inactive conformation of SARS-CoV-2 main protease 115
Features and potentials of ATP-site directed CK2 inhibitors 114
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer 114
Structural basis of CK2 regulation by autoinhibitory oligomerization 114
Insight into GFPmut2 pH Dependence by Single Crystal Microspectrophotometry and X-ray Crystallography 114
Molecular architecture and the structural basis for anion interaction in prestin and SLC26 transporters 113
Conformational Properties of the Amphipathic Lytic Polypeptide Bombolitin-ii - A Circular-dichroism, Nmr and Computer-simulation Study 112
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship. 109
Conformational and Binding-studies On Peptides Related To Domain-i and Domain-iii of Calmodulin 106
Crystal structure of the B subunit of Escherichia coli heat-labile enterotoxin carrying peptides with anti-herpes simplex virus type 1 activity. 106
The crystal structure of the complex of Zea mays alpha subunit with a fragment of human beta subunit provides the clue to the architecture of protein kinase CK2 holoenzyme. 104
A Structural Model for Prestin and Related SLC26 Anion Transporters 102
Susceptibility of the prion protein to enzymatic phosphorylation 101
Comparative molecular dynamics investigation of the electromotile hearing protein prestin 99
Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate 98
Structure-activity relationship of protein kinase CK2 inhibitors with different scaffolds 98
Conformational studies on bombolitin III-related peptides in aqueous solution containing SDS 97
Structural features of protein kinase CK2. 94
A comparative analysis of the properties of Dpl and PrPC. 92
Towards the understanding of molecular aspects of Helicobacter pylori cag-PAI 91
Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight 90
Distinctive binding and structural properties of piscine transthyretin 89
Characterization of the oligomeric states of the CK2 alpha2beta2 holoenzyme in solution 86
Crystal structure of antigen TpF1 from Treponema pallidum. 85
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot - Models for collagen catabolism by matrix-metalloproteases 81
Allostery in homodimeric SARS-CoV-2 main protease 79
Generation of mutants of CK2 alpha which are dependent on the beta-subunit for catalytic activity. 79
Structural and functional determinants of protein kinase CK2 alpha: facts and open questions 79
Structural bases of protein kinase CK2 function and inhibition. 79
Synthesis of multiple-cystine-peptides. 77
Molecular organisation of the ice nucleation protein InaV from Pseudomonas syringae 75
Structural-properties of Recombinant Domain Iii-3 of Perlecan Containing A Globular Domain Inserted Into An Epidermal-growth-factor-like Motif Rid C-4254-2008 71
One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse 69
Functional and structural characterization of ovine ornithine transcarbamoylase 65
Structural basis for selective inhibition of protein kinase CK2 by ATP site-directed ligands 64
The Natural Human-igg Anti-f(ab')(2) Antibody Recognizes A Conformational Igg1 Hinge Epitope 63
Synthesis of a heterotrimeric triple helical „mini-collagen“ with a C-terminal disulfide knot for induction of the correct register. 62
Structure at 1.44 angstrom resolution of rat serum complement C3D 56
Structural bases of protein kinase CK2 inhibition 50
The OSCP Subunit of ATP Synthase is a Dimer in Solution: Strategy to Induce the Monomeric Protein as a New Tool for Drug Discovery 18
Totale 10.767
Categoria #
all - tutte 37.284
article - articoli 33.527
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.523
Totale 72.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021756 0 0 45 40 34 74 23 92 134 119 120 75
2021/20221.251 28 125 233 68 50 56 54 156 53 32 158 238
2022/2023921 181 109 10 117 135 126 4 53 117 9 44 16
2023/2024474 24 71 57 39 59 37 22 24 21 17 74 29
2024/20252.001 8 122 90 84 272 112 133 167 159 52 337 465
2025/20261.916 354 677 885 0 0 0 0 0 0 0 0 0
Totale 10.767